Journal article
In adults with acute HF, high-intensity care vs. usual care reduced a composite of death or HF readmission at 180 d.
Abstract
SOURCE CITATION: Mebazaa A, Davison B, Chioncel O, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet. 2022;400:1938-52. 36356631.
Authors
Levine M
Journal
Annals of Internal Medicine, Vol. 176, No. 3,
Publisher
American College of Physicians
Publication Date
March 2023
DOI
10.7326/j23-0005
ISSN
1056-8751